Results
|
741.
|
|
|
742.
|
|
|
743.
|
|
|
744.
|
|
|
745.
|
|
|
746.
|
|
|
747.
|
|
|
748.
|
|
|
749.
|
|
|
750.
|
JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability. [electronic resource] by
- Morton, Magda F
- Barrett, Terrance D
- Freedman, Jamie
- Li, Lina
- Rizzolio, Michele C
- Prendergast, Clodagh E
- Wu, Xiaodong
- Moreno, Veronica
- Pyati, Jayashree
- Figueroa, Katherine
- Cagnon, Laurence
- Lagaud, Guy
- Ver Donck, Luc
- Ghoos, Etienne
- Allison, Brett
- Rabinowitz, Michael H
- Shankley, Nigel P
Producer: 20110830
In:
The Journal of pharmacology and experimental therapeutics vol. 338
Availability: No items available.
|
|
751.
|
|
|
752.
|
|
|
753.
|
|
|
754.
|
|
|
755.
|
|
|
756.
|
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands. [electronic resource] by
- Dezube, M
- Sugg, E E
- Birkemo, L S
- Croom, D K
- Dougherty, R W
- Ervin, G N
- Grizzle, M K
- James, M K
- Johnson, M F
- Mosher, J T
Producer: 19950927
In:
Journal of medicinal chemistry vol. 38
Availability: No items available.
|
|
757.
|
|
|
758.
|
|
|
759.
|
|
|
760.
|
|